Related Experiment Video

Updated: Jul 18, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
07:17

Production and Detection of Reactive Oxygen Species (ROS) in Cancers

Published on: November 21, 2011

Participation of reactive oxygen species in diabetes-induced endothelial dysfunction

Jana Zúrová-Nedelcevová1, Jana Navarová, Katarína Drábiková

  • 1Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovakia.

Neuro Endocrinology Letters
|December 13, 2006
PubMed
Abstract

Insights

High blood sugar in diabetes increases harmful reactive oxygen species (ROS), damaging blood vessel function. An antioxidant compound, SMe1EC2, demonstrated a protective effect against this damage.

Area of Science:

  • Cardiovascular Research
  • Diabetes Complications
  • Oxidative Stress Biology

Background:

  • Diabetes mellitus is characterized by hyperglycemia, a condition that can lead to significant vascular complications.
  • Endothelial dysfunction, a precursor to cardiovascular disease, is a known complication of diabetes.

Purpose of the Study:

  • To investigate the link between hyperglycemia, reactive oxygen species (ROS) production, and endothelium-mediated arterial function in experimental diabetes.
  • To evaluate the therapeutic potential of an antioxidant in mitigating diabetes-induced endothelial damage.

Main Methods:

  • Diabetes was induced using streptozotocin (STZ) in rats.
  • Endothelial function was assessed by measuring endothelium-dependent relaxation in aortic rings.
  • Reactive oxygen species (ROS) production was quantified using luminol-enhanced chemiluminescence (CL).
  • Reduced glutathione (GSH) levels were measured in various tissues and plasma.
  • In vitro experiments exposed aortic rings to high glucose concentrations.

Main Results:

  • Diabetic rats exhibited endothelial dysfunction, characterized by reduced aortic relaxation, increased endothelemia, and elevated systolic blood pressure.
  • A significant increase in ROS production was observed in both arterial tissue and blood of diabetic rats.
  • While kidney GSH levels increased, plasma and aortic GSH levels remained unchanged.
  • High glucose exposure in vitro impaired endothelium-dependent relaxation.
  • The antioxidant SMe1EC2 effectively restored impaired endothelium-mediated relaxation.

Conclusions:

  • Hyperglycemia-induced ROS production plays a critical role in mediating endothelial dysfunction in experimental diabetes.
  • The antioxidant SMe1EC2 demonstrates significant protective effects against diabetes-related endothelial damage.
  • These findings highlight the potential of antioxidant therapy in managing vascular complications of diabetes.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...